Family Physicians of St. Joseph
SEPTEMBER 25, 2018
Joseph, the family medicine practice is committed to providing exceptional, affordable, patient-centered primary care in SW Michigan without reliance on insurance companies for payment of services. John Proos, with the goal of providing exceptional care to the patients of Berrien County. Joseph, P.C.,
Physician's Weekly
JUNE 19, 2025
Gowin and his colleagues analyzed data from 1,003 adults between 22 and 36 years of age who had functional magnetic resonance imaging (fMRI), urine toxicology, and cannabis use results collected at one academic site between 2012 and 2015 as part of the Human Connectome Project. The cohort (mean age, 28.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Doctor On Demand
APRIL 16, 2025
For more severe symptoms, in-person care may be the recommended course of treatment, and your virtual provider can help you make that decision. If your symptoms indicate more serious problems, the telehealth provider may refer you for in-person care or testing.
The Clinical Problem Solvers
APRIL 24, 2025
The episode also explores how digital tools can help youth manage their mental health, while also noting the need for culturally relevant care providers. Disparities in Restraint Practices: Disparities in restraint practices are addressed, particularly the disproportionate use of physical and pharmacologic restraints on Black people.
FDA Law Blog
NOVEMBER 1, 2023
Counterarguments abound, many of which were detailed in 2015 in a publication by counsel for the American Clinical Laboratory Association ( here ). FDA’s position is, however, only one side of the story. Specific features of the PR will foreseeably yield new bases for challenge.
33 Charts
OCTOBER 2, 2021
It’s the physics of physician bandwidth: You can’t add something without taking something away. Inconsistency in care delivery So as every provider shapes her practice around MyChart, each will do it in a slightly different way. But this may not be consistently applied by other providers in the same group. How do we fix this?
FDA Law Blog
FEBRUARY 29, 2024
A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. The use of a surrogate endpoint can considerably shorten the time required prior to receiving FDA approval. Patent Nos.
Expert insights. Personalized for you.
52 
Let's personalize your content